Dellora Investments Master Fund LP 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-04 4:53 pm Unchanged |
2025-03-05 | 13G | Tenax Therapeutics, Inc. TENX |
Dellora Investments Master Fund LP | 351,071 8.800% |
0 (Unchanged) |
Filing |
| 2025-01-15 4:14 pm Purchase |
2025-01-08 | 13G | Tenax Therapeutics, Inc. TENX |
Dellora Investments Master Fund LP | 351,071 10.300% |
116,278 (+49.52%) |
Filing |
| 2024-12-05 1:47 pm Purchase |
2024-11-27 | 13G | Tenax Therapeutics, Inc. TENX |
Dellora Investments Master Fund LP | 234,793 6.900% |
234,793 (New Position) |
Filing |